• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于生物工程高级3D肿瘤模型的蛋白质水凝胶

Proteinaceous Hydrogels for Bioengineering Advanced 3D Tumor Models.

作者信息

Blanco-Fernandez Barbara, Gaspar Vítor M, Engel Elisabeth, Mano João F

机构信息

Department of Chemistry, CICECO - Aveiro Institute of Materials, University of Aveiro Campus Universitário de Santiago Aveiro 3810-193 Portugal.

Institute for Bioengineering of Catalonia (IBEC) The Barcelona Institute of Science and Technology Baldiri Reixac 10-12 Barcelona 08028 Spain.

出版信息

Adv Sci (Weinh). 2021 Jan 4;8(4):2003129. doi: 10.1002/advs.202003129. eCollection 2021 Feb.

DOI:10.1002/advs.202003129
PMID:33643799
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7887602/
Abstract

The establishment of tumor microenvironment using biomimetic in vitro models that recapitulate key tumor hallmarks including the tumor supporting extracellular matrix (ECM) is in high demand for accelerating the discovery and preclinical validation of more effective anticancer therapeutics. To date, ECM-mimetic hydrogels have been widely explored for 3D in vitro disease modeling owing to their bioactive properties that can be further adapted to the biochemical and biophysical properties of native tumors. Gathering on this momentum, herein the current landscape of intrinsically bioactive protein and peptide hydrogels that have been employed for 3D tumor modeling are discussed. Initially, the importance of recreating such microenvironment and the main considerations for generating ECM-mimetic 3D hydrogel in vitro tumor models are showcased. A comprehensive discussion focusing protein, peptide, or hybrid ECM-mimetic platforms employed for modeling cancer cells/stroma cross-talk and for the preclinical evaluation of candidate anticancer therapies is also provided. Further development of tumor-tunable, proteinaceous or peptide 3D microtesting platforms with microenvironment-specific biophysical and biomolecular cues will contribute to better mimic the in vivo scenario, and improve the predictability of preclinical screening of generalized or personalized therapeutics.

摘要

利用仿生体外模型建立肿瘤微环境,该模型可重现包括肿瘤支持性细胞外基质(ECM)在内的关键肿瘤特征,对于加速发现更有效的抗癌疗法并进行临床前验证的需求很高。迄今为止,由于其具有生物活性特性,可进一步适应天然肿瘤的生化和生物物理特性,ECM模拟水凝胶已被广泛用于三维体外疾病建模。基于这一趋势,本文讨论了已用于三维肿瘤建模的具有内在生物活性的蛋白质和肽水凝胶的现状。首先,展示了重建这种微环境的重要性以及在体外肿瘤模型中生成ECM模拟三维水凝胶的主要考虑因素。还提供了一个全面的讨论,重点是用于模拟癌细胞/基质相互作用以及用于候选抗癌疗法临床前评估的蛋白质、肽或混合ECM模拟平台。进一步开发具有微环境特异性生物物理和生物分子线索的肿瘤可调、蛋白质或肽三维微测试平台,将有助于更好地模拟体内情况,并提高对通用或个性化疗法临床前筛选的可预测性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d8e/7887602/6ad2162c0fba/ADVS-8-2003129-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d8e/7887602/28680e412187/ADVS-8-2003129-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d8e/7887602/c58734274c2d/ADVS-8-2003129-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d8e/7887602/fef46cbfdc25/ADVS-8-2003129-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d8e/7887602/24f17bb4d616/ADVS-8-2003129-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d8e/7887602/871c3d0cbd8d/ADVS-8-2003129-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d8e/7887602/f0a9fdc57c3d/ADVS-8-2003129-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d8e/7887602/4e570dfda4d9/ADVS-8-2003129-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d8e/7887602/ee047113783d/ADVS-8-2003129-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d8e/7887602/ffb8be244ddd/ADVS-8-2003129-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d8e/7887602/6ad2162c0fba/ADVS-8-2003129-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d8e/7887602/28680e412187/ADVS-8-2003129-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d8e/7887602/c58734274c2d/ADVS-8-2003129-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d8e/7887602/fef46cbfdc25/ADVS-8-2003129-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d8e/7887602/24f17bb4d616/ADVS-8-2003129-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d8e/7887602/871c3d0cbd8d/ADVS-8-2003129-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d8e/7887602/f0a9fdc57c3d/ADVS-8-2003129-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d8e/7887602/4e570dfda4d9/ADVS-8-2003129-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d8e/7887602/ee047113783d/ADVS-8-2003129-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d8e/7887602/ffb8be244ddd/ADVS-8-2003129-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d8e/7887602/6ad2162c0fba/ADVS-8-2003129-g010.jpg

相似文献

1
Proteinaceous Hydrogels for Bioengineering Advanced 3D Tumor Models.用于生物工程高级3D肿瘤模型的蛋白质水凝胶
Adv Sci (Weinh). 2021 Jan 4;8(4):2003129. doi: 10.1002/advs.202003129. eCollection 2021 Feb.
2
Stratified 3D Microtumors as Organotypic Testing Platforms for Screening Pancreatic Cancer Therapies.分层 3D 微肿瘤作为用于筛选胰腺癌疗法的器官型测试平台。
Small Methods. 2021 May;5(5):e2001207. doi: 10.1002/smtd.202001207. Epub 2021 Feb 10.
3
Hyaluronan-Based Hydrogels for 3D Modeling of Tumor Tissues.基于透明质酸的水凝胶用于肿瘤组织的 3D 建模。
Tissue Eng Part C Methods. 2024 Oct;30(10):452-499. doi: 10.1089/ten.TEC.2024.0271.
4
In-air production of 3D co-culture tumor spheroid hydrogels for expedited drug screening.空气中生产 3D 共培养肿瘤球体水凝胶用于加速药物筛选。
Acta Biomater. 2019 Aug;94:392-409. doi: 10.1016/j.actbio.2019.06.012. Epub 2019 Jun 12.
5
Decellularized Extracellular Matrix for Bioengineering Physiomimetic 3D in Vitro Tumor Models.去细胞细胞外基质用于生物工程仿生 3D 体外肿瘤模型。
Trends Biotechnol. 2020 Dec;38(12):1397-1414. doi: 10.1016/j.tibtech.2020.04.006. Epub 2020 May 13.
6
Hydrogel 3D in vitro tumor models for screening cell aggregation mediated drug response.用于筛选细胞聚集介导的药物反应的水凝胶 3D 体外肿瘤模型。
Biomater Sci. 2020 Mar 31;8(7):1855-1864. doi: 10.1039/c9bm02075f.
7
Engineering Cellular Microenvironments with Photo- and Enzymatically Responsive Hydrogels: Toward Biomimetic 3D Cell Culture Models.用光和酶响应水凝胶工程化细胞微环境:构建仿生 3D 细胞培养模型。
Acc Chem Res. 2017 Apr 18;50(4):703-713. doi: 10.1021/acs.accounts.6b00543. Epub 2017 Mar 27.
8
Organotypic 3D decellularized matrix tumor spheroids for high-throughput drug screening.用于高通量药物筛选的器官型 3D 脱细胞基质肿瘤球体。
Biomaterials. 2021 Aug;275:120983. doi: 10.1016/j.biomaterials.2021.120983. Epub 2021 Jun 21.
9
Design of spherically structured 3D in vitro tumor models -Advances and prospects.球型结构 3D 体外肿瘤模型设计 - 进展与展望。
Acta Biomater. 2018 Jul 15;75:11-34. doi: 10.1016/j.actbio.2018.05.034. Epub 2018 May 23.
10
Programmable Living Units for Emulating Pancreatic Tumor-Stroma Interplay.可编程活体单元模拟胰腺肿瘤-基质相互作用。
Adv Healthc Mater. 2022 Jul;11(13):e2102574. doi: 10.1002/adhm.202102574. Epub 2022 Apr 24.

引用本文的文献

1
Exo-miR-1911-5p regulates ferroptosis to promote macrophages M2 polarization-mediated gastric cancer cisplatin resistance via MYB/AKR1B10/ACC.外泌体 miR-1911-5p 通过 MYB/AKR1B10/ACC 调节铁死亡,以促进巨噬细胞 M2 极化介导的胃癌顺铂耐药。
Commun Biol. 2025 Jul 15;8(1):1054. doi: 10.1038/s42003-025-08441-w.
2
Highly Strong and Transparent Hydrogel Elastomers Microfabricated for 3D Microphysiological Systems.用于3D微生理系统的超坚固且透明的水凝胶弹性体微加工制品。
ACS Appl Mater Interfaces. 2025 Jul 23;17(29):42394-42406. doi: 10.1021/acsami.5c07880. Epub 2025 Jul 10.
3
Rational design matrix materials for organoid development and application in biomedicine.

本文引用的文献

1
Gelatin-Based Matrices as a Tunable Platform To Study in Vitro and in Vivo 3D Cell Invasion.基于明胶的基质作为一种可调节平台用于研究体外和体内3D细胞侵袭
ACS Appl Bio Mater. 2019 Feb 18;2(2):916-929. doi: 10.1021/acsabm.8b00767. Epub 2019 Jan 31.
2
3D Printed Tissue Models: Present and Future.3D打印组织模型:现状与未来。
ACS Biomater Sci Eng. 2016 Oct 10;2(10):1722-1731. doi: 10.1021/acsbiomaterials.6b00129. Epub 2016 May 6.
3
Modular Cross-Linking of Gelatin-Based Thiol-Norbornene Hydrogels for 3D Culture of Hepatocellular Carcinoma Cells.
用于类器官发育及生物医学应用的理性设计基质材料。
Regen Biomater. 2025 May 14;12:rbaf038. doi: 10.1093/rb/rbaf038. eCollection 2025.
4
Revolutionizing bone healing: the role of 3D models.革新骨愈合:3D模型的作用。
Cell Regen. 2025 Mar 21;14(1):7. doi: 10.1186/s13619-025-00225-1.
5
Harnessing Macrophages in Cancer Therapy: from Immune Modulators to Therapeutic Targets.利用巨噬细胞进行癌症治疗:从免疫调节剂到治疗靶点。
Int J Biol Sci. 2025 Feb 26;21(5):2235-2257. doi: 10.7150/ijbs.106275. eCollection 2025.
6
Vascularised organoids: Recent advances and applications in cancer research.血管化类器官:癌症研究中的最新进展与应用
Clin Transl Med. 2025 Mar;15(3):e70258. doi: 10.1002/ctm2.70258.
7
Enzyme-responsive vitamin D-based micelles for paclitaxel-controlled delivery and synergistic pancreatic cancer therapy.用于紫杉醇控释和协同胰腺癌治疗的酶响应性维生素D基胶束
Mater Today Bio. 2025 Feb 4;31:101555. doi: 10.1016/j.mtbio.2025.101555. eCollection 2025 Apr.
8
3D Microtumors Representing Ovarian Cancer Minimal Residual Disease Respond to the Fatty Acid Oxidation Inhibitor Perhexiline.代表卵巢癌微小残留病的3D微肿瘤对脂肪酸氧化抑制剂哌克昔林有反应。
Adv Healthc Mater. 2025 May;14(14):e2404072. doi: 10.1002/adhm.202404072. Epub 2025 Feb 9.
9
Biomimetic Hydrogel Strategies for Cancer Therapy.用于癌症治疗的仿生水凝胶策略
Gels. 2024 Jun 30;10(7):437. doi: 10.3390/gels10070437.
10
Research Progress in the Field of Tumor Model Construction Using Bioprinting: A Review.生物打印构建肿瘤模型领域的研究进展:综述。
Int J Nanomedicine. 2024 Jun 27;19:6547-6575. doi: 10.2147/IJN.S460387. eCollection 2024.
用于肝癌细胞三维培养的明胶基硫醇-降冰片烯水凝胶的模块化交联
ACS Biomater Sci Eng. 2015 Dec 14;1(12):1314-1323. doi: 10.1021/acsbiomaterials.5b00436. Epub 2015 Oct 29.
4
Collagen Fiber Architecture Regulates Hypoxic Sarcoma Cell Migration.胶原纤维结构调控缺氧肉瘤细胞迁移。
ACS Biomater Sci Eng. 2018 Feb 12;4(2):400-409. doi: 10.1021/acsbiomaterials.7b00056. Epub 2017 May 8.
5
Lung Adenocarcinoma Cell Responses in a 3D in Vitro Tumor Angiogenesis Model Correlate with Metastatic Capacity.三维体外肿瘤血管生成模型中肺腺癌细胞的反应与转移能力相关。
ACS Biomater Sci Eng. 2018 Feb 12;4(2):368-377. doi: 10.1021/acsbiomaterials.7b00011. Epub 2017 Jul 26.
6
Biomolecule-Conjugated Macroporous Hydrogels for Biomedical Applications.用于生物医学应用的生物分子共轭大孔水凝胶
ACS Biomater Sci Eng. 2019 Dec 9;5(12):6320-6341. doi: 10.1021/acsbiomaterials.9b00778. Epub 2019 Nov 22.
7
Collagen Type I-Gelatin Methacryloyl Composites: Mimicking the Tumor Microenvironment.I型胶原蛋白-甲基丙烯酰化明胶复合材料:模拟肿瘤微环境
ACS Biomater Sci Eng. 2019 Jun 10;5(6):2887-2898. doi: 10.1021/acsbiomaterials.9b00264. Epub 2019 May 9.
8
Recent advances in bio-orthogonal and dynamic crosslinking of biomimetic hydrogels.仿生水凝胶的生物正交和动态交联的最新进展。
J Mater Chem B. 2020 Sep 21;8(35):7835-7855. doi: 10.1039/d0tb01429j. Epub 2020 Jul 21.
9
Near-infrared-light regulated angiogenesis in a 4D hydrogel.近红外光调控的4D水凝胶中的血管生成
Nanoscale. 2020 Jul 2;12(25):13654-13661. doi: 10.1039/d0nr02552f.
10
Biomimetic hydrogels with spatial- and temporal-controlled chemical cues for tissue engineering.具有时空控制化学线索的仿生水凝胶用于组织工程。
Biomater Sci. 2020 Jun 21;8(12):3248-3269. doi: 10.1039/d0bm00263a. Epub 2020 Jun 3.